{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Randomized, Open-label Study of HLX10 plus Chemotherapy (Carboplatin- Etoposide) in comparison with Atezolizumab plus Chemotherapy in Previously Untreated US Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) (ASTRIDE)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-randomized-open-label-study-of-hlx10-plus-chemotherapy-carboplatin-etoposide-in-comparison-with-atezolizumab-plus-chemotherapy-in-previously-untreated-us-patients-with-extensive-stage-small-cell\/#breadcrumbitem"}]}